The Cooper Companies ( COO ) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Besides Wall Street's top-and-bottom-line estimates for The Cooper Companies (COO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.
The Cooper Companies ( COO ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The Cooper Companies (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds
COO leans on innovation and diversification to fuel growth, but fertility softness, tariffs and inventory headwinds weigh on near-term outlook.
Plus Therapeutics ( PSTV ) Reports Q2 Loss, Misses Revenue Estimates
Plus (PSTV) delivered earnings and revenue surprises of +88.89% and -18.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies
Despite tariff headwinds and softer elective procedure demand, McKesson, Cardinal Health, West Pharmaceutical Services, and The Cooper Companies are positioned for steady gains in the dental supplies space.
4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
Becton Dickinson ( BDX ) Surpasses Q3 Earnings and Revenue Estimates
Becton Dickinson (BDX) delivered earnings and revenue surprises of +7.60% and +0.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
McKesson ( MCK ) Surpasses Q1 Earnings and Revenue Estimates
McKesson (MCK) delivered earnings and revenue surprises of +0.36% and +1.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings?
BD's third-quarter fiscal 2025 results are likely to benefit from product launches across Medical and Interventional segments, which drive strong revenue potential.
All You Need to Know About The Cooper Companies ( COO ) Rating Upgrade to Buy
The Cooper Companies (COO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
COO or SAUHY: Which Is the Better Value Stock Right Now?
COO vs. SAUHY: Which Stock Is the Better Value Option?
Will GLP-1 Demand Drive MCK's Top Line This Earnings Season?
MCK's Q1 results are expected to reflect strong prescription volume growth from GLP-1 demand, but lower margins may weigh on profitability.
COO Stock Declines Despite Strong Core Growth Amid Fertility Woes
The Cooper Companies grows margins and premium products, but fertility softness, inventory cuts, and tariffs weigh on the near-term outlook.
This Cooper Companies Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday - Cooper Companies ( NASDAQ:COO ) , Alkermes ( NASDAQ:ALKS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst David Saxon upgraded the rating for The Cooper Companies, Inc.
Understanding The Cooper Companies ( COO ) Reliance on International Revenue
Explore The Cooper Companies' (COO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?
Cooper Companies beats fiscal second-quarter estimates and raises guidance, but faces fertility headwinds and inventory pressures. Is COO still a long-term growth play?
XRAY vs. COO: Which Stock Should Value Investors Buy Now?
XRAY vs. COO: Which Stock Is the Better Value Option?
COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down
COO's fiscal Q2 earnings and sales beat market expectations on the back of strong growth. Improvement in operating margin bodes well.
Elastic, Gap, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Cooper Companies ( NASDAQ:COO ) , American Eagle Outfitters ( NYSE:AEO )
U.S. stock futures were lower this morning, with the Dow futures falling around 0.1% on Friday. Shares of Elastic N.V. ESTC fell sharply in today's pre-market trading after the company reported fourth-quarter results. Elastic posted adjusted earnings of 47 cents per share, beating market ...
The Cooper Companies ( COO ) Surpasses Q2 Earnings and Revenue Estimates
The Cooper Companies (COO) delivered earnings and revenue surprises of 3.23% and 0.67%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Retain The Cooper Companies Stock in Your Portfolio Now
COO benefits from the strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning.
Insights Into The Cooper Companies ( COO ) Q2: Wall Street Projections for Key Metrics
Evaluate the expected performance of The Cooper Companies (COO) for the quarter ended April 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Cooper Companies Q2 Earnings Likely to Reflect Seasonal Trends
COO's fiscal second-quarter results are expected to follow seasonal trends, with a lighter start compared to the previous two reported quarters.
Zomedica Corp. ( ZOMDF ) Reports Q1 Loss, Lags Revenue Estimates
Zomedica (ZOMDF) delivered earnings and revenue surprises of -100% and 16.45%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
XRAY or COO: Which Is the Better Value Stock Right Now?
XRAY vs. COO: Which Stock Is the Better Value Option?
Dentsply International ( XRAY ) Surpasses Q1 Earnings and Revenue Estimates
Dentsply (XRAY) delivered earnings and revenue surprises of 48.28% and 3.22%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Staar Surgical ( STAA ) Reports Q1 Loss, Tops Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of 11.86% and 5.57%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Cardinal Health ( CAH ) Beats Q3 Earnings Estimates
Cardinal (CAH) delivered earnings and revenue surprises of 9.30% and 0.27%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Company News for Mar 10, 2025
Companies in The News Are: COO, IBM, COST, ...
Cooper Companies Q1 Earnings In Line, Revenues Miss, Stock Falls
COO's top line fails to meet market expectations despite recording strong growth. However, improvement in operating margin bodes well.
Alliance Witan PLC - Final Results
Alliance Witan PLC ( 'the Company' ) LEI: ...
The Cooper Companies ( COO ) Matches Q1 Earnings Estimates
The Cooper Companies (COO) delivered earnings and revenue surprises of 0% and 1.71%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Cooper Companies Q1 Earnings Likely to Reflect Seasonal Trends
COO's fiscal first-quarter results are expected to follow seasonal trends, with a lighter start compared to the previous two reported quarters.
What Analyst Projections for Key Metrics Reveal About The Cooper Companies ( COO ) Q1 Earnings
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended January 2025.
Dentsply International ( XRAY ) Misses Q4 Earnings and Revenue Estimates
Dentsply (XRAY) delivered earnings and revenue surprises of -39.53% and 1.56%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Patterson Cos. ( PDCO ) Q3 Earnings and Revenues Lag Estimates
Patterson Cos. (PDCO) delivered earnings and revenue surprises of -30.65% and 3.81%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Align Technology ( ALGN ) Beats Q4 Earnings Estimates
Align Technology (ALGN) delivered earnings and revenue surprises of 0.41% and 0.18%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Can Sustained Product Demand Drive BDX Stock Before Q1 Earnings?
The continued solid uptake of BD's products is expected to have driven fiscal first-quarter revenues despite transitory market dynamics.
Reasons to Retain The Cooper Companies Stock in Your Portfolio Now
COO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning.
Are Options Traders Betting on a Big Move in Cooper Companies ( COO ) Stock?
Investors need to pay close attention to Cooper Companies (COO) stock based on the movements in the options market lately.
Jim Cramer: Abbott Laboratories 'Legal Stuff' Is Behind Them - Archer Aviation ( NYSE:ACHR ) , Abbott Laboratories ( NYSE:ABT )
On CNBC's "Mad Money Lightning Round," Jim Cramer said Occidental Petroleum OXY is one of his "least favorite oils."
Girard Sharp LLP CASE UPDATE: Embryo Destruction Lawsuit Against CooperSurgical and the Cooper Companies - Court Denies Defendants' Motions to Dismiss
SAN FRANCISCO, Dec. 11, 2024 ( GLOBE NEWSWIRE ) -- On December 4, 2024, Judge Jon S. Tigar of the U.S.
The Cooper Companies ( COO ) International Revenue in Focus: Trends and Expectations
Explore how The Cooper Companies' (COO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls
COO's top line fails to meet market expectations despite recording strong growth. However, improvement in operating margin bodes well.
The Cooper Companies ( COO ) Q4 Earnings Beat Estimates
The Cooper Companies (COO) delivered earnings and revenue surprises of 4% and 0.89%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Strong Segmental Sales to Drive Cooper Companies Q4 Earnings?
COO's fiscal fourth-quarter results are likely to reflect segmental strength.
Unveiling The Cooper Companies ( COO ) Q4 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for The Cooper Companies (COO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2024.
Macro Challenges to Hurt Patterson Companies' Q2 Earnings?
PDCO's fiscal second-quarter results are likely to reveal a decline in both the Dental and Animal Health segments, reflecting challenges like moderating traffic to clinics.
Ocugen ( OCGN ) Reports Q3 Loss, Misses Revenue Estimates
Ocugen (OCGN) delivered earnings and revenue surprises of 0% and 5.33%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Biote Corp. ( BTMD ) Beats Q3 Earnings Estimates
biote Corp. (BTMD) delivered earnings and revenue surprises of 266.67% and 0%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
